Munther A. Khamashta

63.9k total citations · 16 hit papers
411 papers, 31.3k citations indexed

About

Munther A. Khamashta is a scholar working on Rheumatology, Hematology and Immunology. According to data from OpenAlex, Munther A. Khamashta has authored 411 papers receiving a total of 31.3k indexed citations (citations by other indexed papers that have themselves been cited), including 354 papers in Rheumatology, 106 papers in Hematology and 97 papers in Immunology. Recurrent topics in Munther A. Khamashta's work include Systemic Lupus Erythematosus Research (343 papers), Platelet Disorders and Treatments (84 papers) and Monoclonal and Polyclonal Antibodies Research (74 papers). Munther A. Khamashta is often cited by papers focused on Systemic Lupus Erythematosus Research (343 papers), Platelet Disorders and Treatments (84 papers) and Monoclonal and Polyclonal Antibodies Research (74 papers). Munther A. Khamashta collaborates with scholars based in United Kingdom, Spain and United States. Munther A. Khamashta's co-authors include Graham R.V. Hughes, Guillermo Ruiz‐Irastorza, Manuel Ramos‐Casals, Pilar Brito‐Zerón, David D’Cruz, María Laura Bertolaccini, Beverley J. Hunt, María José Cuadrado, Ricard Cervera and Ronald A. Asherson and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Munther A. Khamashta

401 papers receiving 30.3k citations

Hit Papers

International consensus s... 1989 2026 2001 2013 1999 1995 2003 2020 2013 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshop
    1999 1.9k citations Robin L. Brey, Graham R.V. Hughes et al. profile →
  2. The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome
    1995 1000 citations Munther A. Khamashta, Graham R.V. Hughes et al. profile →
  3. Morbidity and Mortality in Systemic Lupus Erythematosus During a 10-Year Period
    2003 987 citations Ricard Cervera, Munther A. Khamashta et al. Medicine profile →
  4. Immune-related adverse events of checkpoint inhibitors
    2020 931 citations Manuel Ramos‐Casals, Munther A. Khamashta et al. profile →
  5. Adult haemophagocytic syndrome
    2013 899 citations Manuel Ramos‐Casals, Munther A. Khamashta et al. profile →
  6. Systemic Lupus Erythematosus
    1993 706 citations Ricard Cervera, Munther A. Khamashta et al. Medicine profile →
  7. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review
    2008 701 citations Guillermo Ruiz‐Irastorza, Manuel Ramos‐Casals et al. Annals of the Rheumatic Diseases profile →
  8. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation
    2016 689 citations Munther A. Khamashta, Guillermo Ruiz‐Irastorza et al. Annals of the Rheumatic Diseases profile →
  9. Systemic lupus erythematosus
    2007 679 citations Munther A. Khamashta, Graham R.V. Hughes et al. profile →
  10. The "primary" antiphospholipid syndrome: major clinical and serological features.
    1989 668 citations Munther A. Khamashta, Graham R.V. Hughes et al. PubMed profile →
  11. Anifrolumab, an Anti–Interferon‐α Receptor Monoclonal Antibody, in Moderate‐to‐Severe Systemic Lupus Erythematosus
    2016 618 citations Richard Furie, Munther A. Khamashta et al. profile →
  12. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines
    2003 547 citations Ricard Cervera, Doruk Erkan et al. Lupus profile →
  13. Autoimmune Diseases Induced by TNF-Targeted Therapies
    2007 540 citations Manuel Ramos‐Casals, María Laura Bertolaccini et al. Medicine profile →
  14. Antiphospholipid syndrome
    2010 523 citations Guillermo Ruiz‐Irastorza, Mark Crowther et al. profile →
  15. Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study
    2016 382 citations Munther A. Khamashta, Richard Furie et al. Annals of the Rheumatic Diseases profile →
  16. Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial
    2016 278 citations Hannah Cohen, María Laura Bertolaccini et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Munther A. Khamashta United Kingdom 84 22.6k 10.1k 8.7k 4.1k 3.5k 411 31.3k
Ricard Cervera Spain 79 21.8k 1.0× 8.4k 0.8× 7.4k 0.9× 3.8k 0.9× 4.0k 1.2× 562 29.5k
Pier Luigi Meroni Italy 81 18.0k 0.8× 9.0k 0.9× 7.6k 0.9× 3.7k 0.9× 3.1k 0.9× 621 28.6k
Anǵela Tincani Italy 71 15.0k 0.7× 7.2k 0.7× 5.9k 0.7× 2.9k 0.7× 2.6k 0.7× 451 21.3k
Michelle Petri United States 99 25.7k 1.1× 16.7k 1.7× 3.2k 0.4× 7.3k 1.8× 3.2k 0.9× 534 33.5k
Dennis J. McShane United States 24 27.6k 1.2× 10.6k 1.0× 5.1k 0.6× 5.5k 1.4× 2.6k 0.8× 31 39.4k
Jane G. Schaller United States 32 23.7k 1.0× 10.5k 1.0× 6.2k 0.7× 5.5k 1.3× 1.5k 0.4× 91 33.2k
Graham R.V. Hughes United Kingdom 68 13.6k 0.6× 4.4k 0.4× 4.3k 0.5× 2.5k 0.6× 1.7k 0.5× 263 18.2k
Yoshiya Tanaka Japan 80 14.5k 0.6× 9.6k 1.0× 5.2k 0.6× 3.0k 0.7× 951 0.3× 1.1k 30.4k
Michael D. Lockshin United States 52 13.0k 0.6× 5.2k 0.5× 4.8k 0.6× 2.0k 0.5× 2.3k 0.7× 182 17.0k
Ronald van Vollenhoven Sweden 80 20.6k 0.9× 10.0k 1.0× 6.8k 0.8× 4.8k 1.2× 672 0.2× 512 27.7k

Countries citing papers authored by Munther A. Khamashta

Since Specialization
Citations

This map shows the geographic impact of Munther A. Khamashta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Munther A. Khamashta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Munther A. Khamashta more than expected).

Fields of papers citing papers by Munther A. Khamashta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Munther A. Khamashta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Munther A. Khamashta. The network helps show where Munther A. Khamashta may publish in the future.

Co-authorship network of co-authors of Munther A. Khamashta

This figure shows the co-authorship network connecting the top 25 collaborators of Munther A. Khamashta. A scholar is included among the top collaborators of Munther A. Khamashta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Munther A. Khamashta. Munther A. Khamashta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Khamashta, Munther A. & Graham R.V. Hughes. (2024). Hughes syndrome: The discovery of the antiphospholipid syndrome. Medicina Clínica. 163. S1–S3.
3.
Askanase, Anca, Richard Furie, Maria Dall’Era, et al.. (2024). Disease-modifying therapies in systemic lupus erythematosus for extrarenal manifestations. Lupus Science & Medicine. 11(1). e001124–e001124. 4 indexed citations
4.
Furie, Richard, Maria Dall’Era, Andrew S. Bomback, et al.. (2023). AB0531 APPLYING THE WORKING DEFINITION OF THE DISEASE MODIFICATION CRITERIA TO LUPUS NEPHRITIS TREATMENTS FROM THE PUBLISHED LITERATURE. Annals of the Rheumatic Diseases. 82. 1463–1464. 1 indexed citations
5.
Pérez‐Sánchez, C., Nuria Barbarroja, Patricia Ruiz‐Limón, et al.. (2014). Gene profiling reveals specific molecular pathways in the pathogenesis of atherosclerosis and cardiovascular disease in antiphospholipid syndrome, systemic lupus erythematosus and antiphospholipid syndrome with lupus. Annals of the Rheumatic Diseases. 74(7). 1441–1449. 75 indexed citations
6.
Khamashta, Munther A., et al.. (2013). Recurrent atraumatic metatarsal, rib and sacral insufficiency fractures in a woman with the antiphospholipid syndrome. BMJ Case Reports. 2013. bcr2013201311–bcr2013201311. 6 indexed citations
7.
Cohen, Hannah, et al.. (2013). RAPS: a prospective randomised controlled phase II/III clinical trial of rivaroxaban vs. warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE. UCL Discovery (University College London). 1 indexed citations
8.
Ramos‐Casals, Manuel, et al.. (2013). [Belimumab in systemic lupus erythematosus: a guide for its use in the daily practice].. PubMed. 213(1). 66–7. 10 indexed citations
9.
Khamashta, Munther A. & Manuel Ramos‐Casals. (2011). Autoimmune diseases : acute and complex situations. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 5 indexed citations
10.
11.
12.
D’Cruz, D., Munther A. Khamashta, Matthew Arno, et al.. (2007). Anti-β2GPI-antibody-induced endothelial cell gene expression profiling reveals induction of novel pro-inflammatory genes potentially involved in primary antiphospholipid syndrome. Annals of the Rheumatic Diseases. 66(8). 1000–1007. 39 indexed citations
13.
Khamashta, Munther A.. (2006). Systemic lupus erythematosus and pregnancy. Best Practice & Research Clinical Rheumatology. 20(4). 685–694. 59 indexed citations
14.
Bertolaccini, María Laura, Tatsuya Atsumi, T Koike, G R Hughes, & Munther A. Khamashta. (2004). Antiprothrombin antibodies detected in two different assay systems: Prevalence and clinical significance in systemic lupus erythematosus. Research Portal (King's College London). 50(9). 4 indexed citations
15.
Cuadrado, M J, Giuseppe D. Sanna, M. K. Sharief, Munther A. Khamashta, & G R Hughes. (2003). Double blind, crossover, randomised trial comparing low molecular weight heparin versus placebo in the treatment of chronic headache. Research Portal (King's College London). 48(9). 2 indexed citations
16.
Hunt, B. J., et al.. (2002). Longitudinal analysis of serum insulin-like growth factor-I and insulin-like growth factor binding protein-1 in antiphospholipid syndrome and healthy pregnancy.. Blood. 100(11). 1 indexed citations
17.
Jean, R, María Laura Bertolaccini, Giovanni Sanna, Munther A. Khamashta, & G R Hughes. (2000). Outcome in patients with anticardiolipin antibodies: A prospective 4 years follow-up. Journal of Autoimmunity. 15. 2 indexed citations
18.
Khamashta, Munther A.. (2000). Hughes syndrome : antiphospholipid syndrome. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 47 indexed citations
19.
Cervera, Ricard, Munther A. Khamashta, Josep Font, et al.. (1999). Morbidity and Mortality in Systemic Lupus Erythematosus During a 5-Year Period: A Multicenter Prospective Study of 1,000 Patients. Medicine. 78(3). 167–175. 315 indexed citations
20.
Cervera, Ricard, Munther A. Khamashta, Josep Font, et al.. (1993). Systemic Lupus Erythematosus. Medicine. 72(2). 113–124. 706 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ricard Cervera Breakdown of academic impact, for papers by Pier Luigi Meroni Breakdown of academic impact, for papers by Anǵela Tincani Breakdown of academic impact, for papers by Michelle Petri Breakdown of academic impact, for papers by Dennis J. McShane Breakdown of academic impact, for papers by Jane G. Schaller Breakdown of academic impact, for papers by Graham R.V. Hughes Breakdown of academic impact, for papers by Yoshiya Tanaka Breakdown of academic impact, for papers by Michael D. Lockshin Breakdown of academic impact, for papers by Ronald van Vollenhoven
Rankless by CCL
2026